Ruboxistaurin Completed Phase 2 Trials for Diabetic Neuropathies Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00190970The Effect of Ruboxistaurin on Small Fiber Function